Sorafenib inhibits ABCG2 and overcomes irinotecan resistance−response

Journal article

Peer reviewed

Molecular Cancer Therapeutics, Vol.13

2014

PMID: 24615775

Abstract

Humans

Animals

ATP-Binding Cassette Transporters/*genetics

Camptothecin/*analogs & derivatives

Colorectal Neoplasms/*drug therapy

Neoplasm Proteins/*genetics

Niacinamide/*analogs & derivatives

Phenylurea Compounds/*administration & dosage

url

Find in HALView

1 Record Views

Title: Sorafenib inhibits ABCG2 and overcomes irinotecan resistance−response
Creators - without role: Celine Gongora - Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier - IRCM
Publication Details: Molecular Cancer Therapeutics, Vol.13
Identifiers: 9945869709311
Academic Unit: Institut de Recherche en Cancérologie de Montpellier - IRCM
Language: English
Resource Type: Journal article
Local Fields: hal-02168059